Category: ‘Therapies and Procedures’
Posted on December 7th, 2021
‘Don’t want to raise hopes unreasonably, but I’m increasingly convinced that this could be done’
Elon Musk has said he does not want to “raise hopes unreasonably” but is “increasingly confident” his brain-machine interface startup Neuralink will have its first implant devices in humans by 2022.
Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells Stem Cell Treatment for Traumatic Spinal Cord Injury
Posted on November 11th, 2021
Dutch biotech company, Neuroplast, and the Hospital Nacional de Parapléjicos de Toledo in Spain have announced positive clinical Phase I results after analysis of ten patients suffering from traumatic spinal cord injury (TSCI), with data demonstrating that its investigational stem cell treatment, Neuro-Cells, appears to be safe and well tolerated, without product-related adverse events.
The treatment uses the patient’s own stem cells to prevent further loss of function after sustaining TSCI, in an effort to limit loss of mobility and independence of otherwise life-long impairment.
Posted on July 23rd, 2021
Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say.
Posted on January 12th, 2021
Almost 18,000 Americans experience traumatic spinal cord injuries every year. Many of these people are unable to use their hands and arms and can’t do everyday tasks such as eating, grooming or drinking water without help.
Posted on August 14th, 2020
Osmotic therapy device reduces swelling to prevent secondary injuries in rats
When injured, the spinal cord swells, restricting blood flow and causing critical and permanent motor, sensory, and autonomic function damage. Rapid prevention of spinal cord swelling immediately after injury is key to preventing more serious damage. The only treatment to date has been steroid therapy with methylprednisolone, which is minimally effective.